Your session is about to expire
← Back to Search
MRI
Optimized MRI for Hip Arthritis
N/A
Recruiting
Led By Iman Khodarahmi, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients aged ≥ 18 with unilateral symptomatic (e.g. pain) total hip arthroplasty
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1, day 0
Awards & highlights
Study Summary
This trial will compare how well two types of MRI work in reducing metal-related artifacts in patients with hip arthroplasty implants.
Who is the study for?
This trial is for adults over 18 with hip arthritis who have had a hip replacement on one side and are experiencing symptoms like pain. They must be able to undergo MRI scans, meaning no severe claustrophobia or other metal implants, and not pregnant. Those with recent hip surgery or needing contrast material for MRI can't participate.Check my eligibility
What is being tested?
The study tests an optimized MRI technique designed to reduce image distortion caused by metal from hip replacements. Participants will receive two MRIs: one using standard settings and another with the modified approach that optimizes radiofrequency pulse polarization.See study design
What are the potential side effects?
Since this trial involves only MRI scanning, there are typically no direct side effects from the procedure itself aside from discomfort due to lying still in a confined space which might trigger claustrophobia in susceptible individuals.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18 and have pain in one hip after a total hip replacement.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ visit 1, day 0
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 1, day 0
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment of the size of the artifact-degraded regions
Secondary outcome measures
Assessment of the abnormality detection rate
Assessment of the visibility of normal structures
Trial Design
1Treatment groups
Experimental Treatment
Group I: MRI groupExperimental Treatment1 Intervention
Subjects enrolled in this study will undergo both standard and new MRI techniques. The standard MRI is needed for your routine care and as ordered by the referring doctor. The new MRI is performed for research purposes. Participants will be imaged with both methods and the results will be compared.
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,373 Previous Clinical Trials
841,097 Total Patients Enrolled
Radiological Society of North AmericaOTHER
25 Previous Clinical Trials
1,797 Total Patients Enrolled
ISS, Inc.Industry Sponsor
2 Previous Clinical Trials
359 Total Patients Enrolled
Media Library
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Share this study with friends
Copy Link
Messenger